<p>This study is from a phase I clinical trial of neoantigen DNA vaccines in triple negative breast cancer patients with persistent disease following neoadjuvant chemotherapy. The exome and RNA sequences used to identify somatic mutations, predict neoantigens, and design vaccines is within.<br></p>

Personalized Breast Cancer Vaccines Based on Genome Sequencing

16 variables across Demographics, Disease Events, Race and Ethnicity

Personalized Breast Cancer Vaccines Based on Genome Sequencing

Demographics (2)

Disease Events (1)

Race and Ethnicity (1)

Other (12)